Cas:3893-01-4 2,3-dimethoxybenzyl chloride manufacturer & supplier

We serve Chemical Name:2,3-dimethoxybenzyl chloride CAS:3893-01-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,3-dimethoxybenzyl chloride

Chemical Name:2,3-dimethoxybenzyl chloride
CAS.NO:3893-01-4
Synonyms:1-(chloromethyl)-2,3-dimethoxybenzene;2,3-Dimethoxybenzyl chloride;MFCD01310812
Molecular Formula:C9H11ClO2
Molecular Weight:186.63500
HS Code:2909309090

Physical and Chemical Properties:
Melting point:69-70.5℃
Boiling point:248.6ºC at 760mmHg
Density:1.13g/cm3
Index of Refraction:1.509
PSA:18.46000
Exact Mass:186.04500
LogP:2.44260

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-(chloromethyl)-2,3-dimethoxybenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD01310812 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD01310812 Use and application,2,3-Dimethoxybenzyl chloride technical grade,usp/ep/jp grade.


Related News: GEM’s phase 3 program, the Champlain Survivor Relocation Fund (https://globalempowermentmission.kindful.com/campaigns/1137367) was created to assist the primary residents of Champlain Towers South Survivors with first, last, and security deposits on their new annual leases. Leading real estate firm, the Alexander Team from Douglas Elliman is providing showings at pro Bono. Heptanedioic acid, 2-amino-6-oxo-, (2S)-, trifluoroacetate manufacturers Importance of evaluating biocatalytic processes during development 1,2,3,4,6,7-Hexahydro-7-imino-1,4-dimethyl-5H-1,4-diazepin-5-on-hydrochlorid suppliers For skin rash, the difference in response rates for anifrolumab versus placebo at week 52 were 13.5% SLE Disease Activity Index (SLEDAI), 15.5% British Isles Lupus Assessment Group index (BILAG) and 15.6% modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). For arthritis, differences in response rates were 8.2% SLEDAI, 11.8% BILAG and 12.6% joint response. 1-(tert-butylamino)-3-(4-(hydroxymethyl)-2-methoxyphenoxy)propan-2-ol vendor & factory.